TSY 0210
Alternative Names: TSY-0210Latest Information Update: 31 May 2023
At a glance
- Originator Formosa Pharmaceuticals
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 20 Apr 2023 Preclinical trials in Bacterial infections in Taiwan (unspecified route) (Formosa Pharmaceuticals pipeline, April 2023)